Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Change in Inventory (2024 - 2025)

Madrigal Pharmaceuticals (MDGL) has disclosed Change in Inventory for 2 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Inventory fell 93.18% to $1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $37.0 million, a 8.54% increase, with the full-year FY2025 number at $37.0 million, up 8.54% from a year prior.
  • Change in Inventory was $1.7 million for Q4 2025 at Madrigal Pharmaceuticals, down from $5.8 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $25.4 million in Q4 2024 to a low of $854000.0 in Q1 2024.